Physician profile
Larry M Walker
NPI 1437122355
$8,857.22
in general payments reported to CMS, 2019-2025
36 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $1,210 · 2021: $1,575 · 2022: $841 · 2023: $152 · 2024: $1,056 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,861.88 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $1,289.57 | 2019-2025 | Freestyle Libre 3, Freestyle Libre |
| Glaxosmithkline, LLC. | $912.19 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $897.49 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Sanofi-Aventis U.S. LLC | $523.58 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $456.44 | 2019-2025 | Spravato |
| Merck Sharp & Dohme LLC | $398.20 | 2019-2021 | |
| Lilly USA, LLC | $291.63 | 2019-2025 | Mounjaro, Jardiance |
| Kowa Pharmaceuticals America, INC. | $280.48 | 2024-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.38 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.24 | 2019-2020 | |
| Amgen INC. | $163.68 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $155.38 | 2021 | |
| Dexcom, INC. | $151.39 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $122.32 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $117.50 | 2019 | |
| Hologic Sales and Service, LLC | $112.54 | 2019-2021 | |
| Abbvie INC. | $102.71 | 2021-2025 | |
| Boston Scientific Corporation | $92.44 | 2025 | Enroute Transcarotid Neuroprotection System |
| Angiodynamics, INC. | $66.29 | 2023 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $51.68 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $49.84 | 2021 | |
| Astellas Pharma US INC | $48.05 | 2021 | |
| Hikma Pharmaceuticals USA | $37.69 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.20 | 2019 | |
| Vanda Pharmaceuticals INC. | $23.11 | 2023 | Fanapt, Hetlioz |
| Insulet Corporation | $22.58 | 2025 | Omnipod |
| Myriad Genetic Laboratories, INC. | $21.69 | 2024 | Genesight |
| Supernus Pharmaceuticals, INC. | $20.45 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $19.87 | 2022 | |
| Gilead Sciences, INC. | $18.62 | 2021 | |
| Optinose US, INC. | $18.24 | 2021 | |
| Nabriva Therapeutics, Plc | $18.00 | 2021 | |
| Pacira Therapeutics, INC. | $16.52 | 2019 | |
| Avion Pharmaceuticals | $12.50 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.